Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Workforce Development topic
No spam. Unsubscribe anytime.
PVCC outlines biotech training plan, pending grants and space needs to serve industry expansion
Summary
Piedmont Virginia Community College told the Albemarle EDA it is developing hands‑on biotech and pharmaceutical manufacturing training—including a simulated clean‑room—supported by pending grants (about $7 million cited) and industry partnerships to meet projected hiring by large employers over the next decade.
Piedmont Virginia Community College representatives briefed the Albemarle County Economic Development Authority on plans to expand biotech and pharmaceutical manufacturing training to meet projected labor demand from area employers.
A PVCC presenter (introduced at the meeting as the college’s executive director for biotechnology and pharmaceutical manufacturing) said the college is seeking space for a state‑of‑the‑art simulated clean‑room training facility, industry‑tuned curriculum and credentialing that would prepare students for jobs in upstream cell culture, downstream analytics and fill–finish manufacturing. The presenter said the program expects to serve roughly 200–300 students a year once fully implemented.
College staff reported about $7,000,000 in pending grants, including a proposal tied to a governor’s laboratory school that would serve 72 juniors and seniors in a biotech pathway; the presenter said that particular funding remains uncertain pending state budget outcomes. The college has also applied to NSF and described other federal and state funding opportunities under review.
On curriculum, PVCC said it is embedding industry‑recognized credentials and aligning course competencies with employer needs, citing consultations with regional companies and national program examples. "We are embedding industry recognized credentials in everything that we do," the presenter said, adding that employers have asked for documentation practices, aseptic technique and professional communication as core competencies.
Board members pressed for timelines and for competency‑based curriculum development tied to employer job tasks; staff pointed to ongoing work with AstraZeneca and other employers and said the major local employer expansions are expected to ramp between the late 2020s and early 2030s, a timeline that factors into space and hiring needs.
PVCC and the EDA agreed to stay in close contact about funding developments and potential site options for a training facility. Staff said it will report back as grant awards and state budget decisions become clear.
